Ivonne Coraza

Intensive lifestyle modification reduces Lp-PLA2 in dyslipidemic HIV/HAART patients.

C. Ballantyne, Vijay Nambi, H. Pownall, 2013, Medicine and science in sports and exercise.

Pathogenesis of A 2 b + Ketosis-Prone Diabetes

C. Newgard, C. Hampe, J. Bain, 2013 .

Pathogenesis of A−β+ Ketosis-Prone Diabetes

C. Newgard, C. Hampe, J. Bain, 2013, Diabetes.

Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome.

A. Balasubramanyam, F. Jahoor, Dinakar Iyer, 2012, Metabolism: clinical and experimental.

Impaired Lipoprotein Processing in HIV Patients on Antiretroviral Therapy: Aberrant High-Density Lipoprotein Lipids, Stability, and Function

H. Pownall, A. Balasubramanyam, Dinakar Iyer, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients.

H. Pownall, A. Balasubramanyam, R. Hoogeveen, 2013, Metabolism: clinical and experimental.

Islet-Specific T-Cell Responses and Proinflammatory Monocytes Define Subtypes of Autoantibody-Negative Ketosis-Prone Diabetes

C. Hampe, J. Palmer, A. Balasubramanyam, 2013, Diabetes Care.

Subtypes of Autoantibody-Negative Ketosis-Prone Diabetes ( KPD )

C. Hampe, J. Palmer, A. Balasubramanyam, 2013 .

Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial.

C. Ballantyne, H. Pownall, T. Giordano, 2011, The Journal of clinical endocrinology and metabolism.